CareDX's Maag 'excited' about geographic expansion
In an exclusive interview with The Fly, CareDx (CDNA) CEO Peter Maag talked about his molecular diagnostics company's upcoming products: "I'm very excited about our geographic expansion, making our products available ex-U.S. Here in the U.S., we have FedEx [FDX]. So, all the blood samples go through our reference laboratory in California, and then we report the test results out to any transplant center in the country. But ex-U.S. that's really not very feasible, with the lack of these established sample flows. So, we will make sure that every transplant center in the world that wants to test cell free DNA, like with an AlloSure type of test, will have the ability to do so in their local transplant lab. This is the AlloSeq franchise: we make our technology available in a distributed model and then the local transplant laboratory can actually perform the test." "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company. The remainder of this interview to follow.